Holen Sie sich die Stockscreener-App
19.64
2.36%
-0.475
Handel nachbörslich:
19.68
0.035
+0.18%
Schlusskurs vom Vortag:
$20.12
Offen:
$20.31
24-Stunden-Volumen:
181.99K
Relative Volume:
0.55
Marktkapitalisierung:
$1.34B
Einnahmen:
$350.00K
Nettoeinkommen (Verlust:
$-72.78M
KGV:
-18.19
EPS:
-1.08
Netto-Cashflow:
$-54.46M
1W Leistung:
+3.07%
1M Leistung:
-8.92%
6M Leistung:
+13.62%
1J Leistung:
+15.36%
1-Tages-Spanne:
$19.30
$20.50
1-Wochen-Bereich:
$17.75
$20.50
52-Wochen-Spanne:
$12.56
$26.30
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
19.64 | 1.37B | 350.00K | -72.78M | -54.46M | -1.08 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Income Plays: Does Pulse Biosciences Inc have strong fundamentalsPortfolio Update Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - Yahoo Finance
Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story? - Sahm
Pulse Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy? - Yahoo Finance
Q4 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Pulse Biosciences hires Liane Teplitsky as COO - MedTech Dive
PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill
Pulse Biosciences names Liane Teplitsky as chief operating officer By Investing.com - Investing.com Australia
Pulse Biosciences, Inc. (PLSE) stock price, news, quote and history - Yahoo Finance Singapore
Pulse Biosciences Strengthens Executive Leadership Team - Investing News Network
Pulse Biosciences appoints new COO to advance commercialization - TipRanks
Pulse Biosciences Appoints Liane Teplitsky as Chief Operating Officer Effective April 8, 2026 - Minichart
Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences - TradingView — Track All Markets
Pulse Biosciences (PLSE) hires new COO with large inducement equity grants - Stock Titan
Pulse Biosciences Names Liane Teplitsky Chief Operating Officer - marketscreener.com
Pulse Biosciences strengthens executive leadership team - marketscreener.com
Pulse Biosciences names Liane Teplitsky as chief operating officer - Investing.com
Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now - Seeking Alpha
Pulse Biosciences Stock Drops 13% In A Day, Why You Shouldn Not Be Buying The Stock - Trefis
How Low Can PLSE Really Go In A Market Crash? - Trefis
Pulse Biosciences Inc Enrolls First Patients in NANOPULSE-AF Ide Pivotal Clinical Study Evaluating nsPFA Cardiac Catheter System for Atrial Fibrillation - marketscreener.com
Pulse Biosciences Enrolls 1st Patient in nPulse PFA Tech Trial for AFib - Medical Product Outsourcing
Pulse Biosciences Inc (PLSE) Shares Gap Down to $19.14 on Apr 7 - GuruFocus
Pulse Biosciences begins pivotal atrial fibrillation trial By Investing.com - Investing.com South Africa
Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study - TipRanks
Pulse Biosciences, Inc. Files 8-K with SEC Detailing Company Information and Nasdaq Listing - Minichart
First patients treated in Pulse Biosciences (NASDAQ: PLSE) NANOPULSE-AF AFib trial - Stock Titan
Pulse Biosciences begins pivotal atrial fibrillation trial - Investing.com
Pulse Biosciences (NASDAQ: PLSE) recently announced that its pivotal clinical study of the Npulse™ Cardiac Catheter System for atrial fibrillation treatment (Nanopulse-Af Ide) has completed enrollment of the first group of patients. - Bitget
Pulse Biosciences enrolls first patients in Nanopulse-AF IDE pivotal clinical study evaluating nPulse(TM) cardiac catheter system for atrial fibrillation - marketscreener.com
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation - TradingView — Track All Markets
PLSE SEC FilingsPulse Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Swings: Is Pulse Biosciences Inc exposed to currency risks2026 PostEarnings & Capital Efficient Trading Techniques - baoquankhu1.vn
How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - Stock Traders Daily
Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge? - Sahm
Pulse Biosciences (PLSE) awards CTO 100,000 Restricted Stock Units - Stock Titan
Pulse Biosciences, Inc. (PLSE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference - 01net
Pulse Biosciences Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Q3 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Q1 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
PLSE accelerates cardiac catheter program after breakthrough AFib data - MSN
Pulse Biosciences Shifts Focus to Catheter Electrophysiology Tech - Medical Product Outsourcing
How Pulse Biosciences’ nPulse AFib Refocus Will Impact Pulse Biosciences (PLSE) Investors - simplywall.st
Pulse Biosciences (NASDAQ:PLSE) Shares Down 7%What's Next? - MarketBeat
PLSE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
1.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):